<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________
FORM 10-KSB/A
(Mark One)
/X/ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended December 31, 1996
OR
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from___________ to ___________
Commission file number 0-25344
_______________________________________
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
(Name of small business issuer)
Nevada 25-1741216
(State or other jurisdiction of) (I.R.S. Employer Identification No.)
Incorporation or organization
1315 Greg Street, Suite 103
Sparks, Nevada 89431
(Address of principal executive offices) (Zip Code)
702-356-2315
(Issuer's telephone number)
Securities registered pursuant to Section 12(b) of the Exchange Act:
None
Securities registered pursuant to Section 12(g) of the Exchange Act:
Common Stock
Check whether the issuer (1) has filed all reports required to be filed
by Section 13 or 15(b) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes X No
----- -----
Check if there is no disclosure of delinquent filers in response to Item
405 of Regulation S-B contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form
10-KSB or any amendment to this Form 10-KSB. /X/
State issuer's revenues for its most recent fiscal year. $9,215,117
----------
State the aggregate market value of the voting stock held by
non-affiliates of the registrant computed by reference to the price at which
the stock was sold, or the average bid and asked prices of such equity, as of
March 27, 1997. $27,131,465
-----------
State the number of shares outstanding of each of the issuer's classes of
equity stock, as of March 27, 1997. 15,015,316
-----------
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the following documents are incorporated herein by reference:
Part III - The registrant's definitive Proxy Statement for its Annual
Meeting of Stockholders, to be filed not later than 120 days after the close
of the fiscal year.
Transitional Small Business Disclosure Format: Yes No X
----- -----
<PAGE>
PART I
ITEM 1. DESCRIPTION OF BUSINESS
General
National Medical Financial Services Corporation (the "Company") is a
Nevada corporation formed in 1994. The Company markets accounting, billing,
collection and accounts receivable management services to medical providers
such as hospital-based and office-based physicians, free-standing medical
providers and hospital-affiliated entities (collectively, "Medical Services
Providers"). The Company also acquires from other entities contracts to
provide such services to Medical Service Providers and may, in the future,
acquire entities that provide such services. The Company subcontracts for
the performance of these services with an entity which is owned by,
controlled by or affiliated with the Company's Chairman, President and Chief
Executive Officer and principal stockholder (the "Chairman"). The Company
plans to continue to expand its client base through its marketing program
and through the acquisition of contracts to provide billing, collection and
accounts receivable management services, as well as accounting services, to
Medical Service Providers. The Company was formed initially as a vehicle
for the outsourcing of billing, collection and accounts receivable
management services, as well as accounting services, which were performed
internally by over 40 Medical Service Providers which are owned by,
controlled by, or affiliated with the Chairman.
The Company currently provides, through subcontractors, services to over
110 Medical Service Providers specializing in providing out-patient radiation
oncology and medical oncology services, as well as nursing homes, emergency
room and out-patient surgery centers located throughout the United States.
A substantial portion of these Medical Service Providers are owned by,
controlled by, or affiliated with the Chairman. The Company intends to
continue to expand its client base to include unaffiliated entities. In
pursuing this goal, the Company expects to draw upon the healthcare and
acquisition experience of its management and outside consultants to identify
and develop new business opportunities, including the expansion of its client
base through the acquisition of client contracts from other businesses that
provide services similar to those marketed by the Company.
Services are generally provided to the Company's clients through a
subcontracting arrangement with Russell Data Services, Inc., a Nevada
company ("Russell Data"), an entity which is owned and controlled by the
Chairman. Such arrangement has not been negotiated on an arm's length basis
and may not be as favorable as that which could have been obtained from a
third party.
On June 30, 1995, the Company acquired the cash, accounts receivable and
client lists of Asterino & Associates, Inc. ("Asterino"), a billing and
collection company located in Schenectady, New York. Asterino was a party
to approximately 20 contracts to provide services to various Medical Service
Providers in the state of New York ranging from single physician practices to
hospital-based physician groups. Asterino's clients are involved in various
medical specialties, including cardiology, radiology and surgery.
Approximately 100 physicians are covered under the Asterino contracts. The
services provided by Asterino under the contracts with its clients provide
for Asterino to develop, implement, manage, operate and supervise billing,
collection and accounts receivable management services for its clients. In
some instances, Asterino provides additional practice management,
accounting services and payroll services. The typical Asterino client
contract provides that Asterino, as an independent contractor, has the sole
responsibility for the
1
<PAGE>
management and supervision of the operation of the services provided. Under
these contracts, Asterino is generally indemnified against claims arising
out of the provisions of services.
On December 1, 1995, the Company acquired a billing contract between
Rapier Investments Ltd. ("Rapier") and University Emergency Medicine
Foundation, Inc. ("UEMF"). UEMF's clients are involved in the emergency
room specialty. Approximately 56 physicians are covered under the this
contract. Pursuant to the contracts rights purchase agreement with Rapier,
the Company has assumed the right to receive payments and the obligation to
provide services with respect to the billing and collection of fees for
medical services provided by UEMF at Rhode Island Hospital.
On February 13, 1996, the Company acquired the accounts receivable and
approximately 25 client contracts of Doctors Medical Billing Service, A
Limited Liability Corporation ("Doctors Medical"), a billing and collection
company located in Las Vegas, Nevada. Doctors Medical's clients are
involved in various medical specialties, including cardiology, emergency
room and primary care. Approximately 90 physicians are covered under the
Doctors Medical contracts. Pursuant to the contracts rights purchase
agreement with Doctors Medical, the Company has assumed the right to receive
payments and the obligation to provide services with respect to the billing
and collection of fees for medical services provided by these Medical
Service Providers.
On April 1, 1996, the Company acquired the accounts receivable and
approximately 19 client contracts of National Medical Services, Inc.
("National Medical"), a billing and collection company located in Las Vegas,
Nevada. National Medical's clients are involved in various medical
specialties, including anesthesiology and primary care. Approximately 90
physicians are covered under the National Medical contracts. Pursuant to
the contracts rights purchase agreement with National Medical, the Company
has assumed the right to receive payments and the obligation to provide
services with respect to the billing and collection of fees for medical
services provided by these Medical Service Providers.
On August 1, 1996, the Company acquired seven additional contracts to
provide billing, collection and accounts receivable management services
between Rapier and Medicine Service Providers in Massachusetts and New
Hampshire. The clients involved with these contracts are in the emergency
room specialty. Approximately 54 physicians are covered under these
contracts. Pursuant to the contracts rights purchase agreement with Rapier,
the Company has assumed the right to receive payments and the obligation to
provide services with respect to the billing and collection of fees for
medical services provided these Medical Service Providers.
On March 1, 1997, the Company acquired a contract to provide billing and
collection services to an emergency medical group in Rhode Island.
Approximately 19 physicians are covered under this contract. Pursuant to
the contracts rights purchase agreement, the Company has assumed the right
to receive payments and the obligation to provide services with respect to
the billing and collection of fees for medical services provided by these
Medical Service Providers.
On March 1, 1997, the Company acquired a contract to provide billing and
collection services to an emergency medical group in the Cleveland, Ohio area.
Approximately 22 physicians are covered under this contract. Pursuant to
the contracts rights purchase agreement, the Company has assumed the right
to receive payments and the obligation to provide services with respect to
the billing and collection of fees for medical services provided by these
Medical Service Providers.
2
<PAGE>
Relationship with Russell Data
The Company has contracted with Russell Data to provide to the Company,
on a non-exclusive basis, certain specified billing and collection services
for a fee of 70 percent of net revenues to be received by the Company for
services billed by Russell Data. The contract is for a term of ten years and
expires on September 20, 2004. Under the terms of the contract, the Company
is permitted to contract with providers of services other than Russell Data
and Russell Data is permitted to provide its services to companies other than
the Company, provided that Russell Data is obligated to service for the
Company all client contracts which are priced at not less than 80% of the
industry standard for similar contracts. The Russell Data contract contains
an arbitration procedure to be followed in the event that any dispute arises
between the parties under the contract.
The contract with Russell Data also provides that: (i) the Company must
provide to Russell Data, at the Company's sole expense, specified customer
information and materials and Russell Data will have no obligation to review
or verify such information; (ii) Russell Data makes no warranties with
respect to the services provided under the contract; (iii) the Company's
sole and exclusive remedy if it determines that a substantial number of
services provided by Russell Data are not being performed in a commercially
reasonable manner such that the Company or its customers will suffer
material detriment is to terminate the contract in accordance with its
terms; (iv) the Company will indemnify Russell Data under certain
conditions; (v) neither Russell Data nor its officers, directors,
stockholders, partners, employees or agents will be liable to the Company
for any damages unless the Company's damages are solely due to the gross
negligence or willful conduct of such party and Russell Data's total maximum
liability is $2,500 therefor, and in no event will Russell Data or such
other parties be liable for (a) any damages caused by the Company's failure
to perform its obligations under the contract, (b) any third party claims
except a claim based on a breach of confidentiality, (c) any loss of profit,
records, files or data, (d) any delay in delivery of services or (e) any
other special, indirect, incidental or consequential damages; (vi) Russell
Data will keep the information and materials it receives from the Company
confidential; (vii) Russell Data may renegotiate the terms of the contract
if there is a significant change in any law, regulation or policy which
materially and adversely affects Russell Data's ability to perform the
contract; and (viii) the Company agrees not to solicit or employ any Russell
Data employee during the term of the contract and for one year thereafter
without the prior written consent of Russell Data.
Russell Data is owned and controlled by the Chairman. Russell Data may
contract with other companies owned by, controlled by, or affiliated with
the Chairman for the subcontracting of services that Russell Data may render
under its contract with the Company. The Company believes that the terms of
the contracts between the Company and companies owned by, controlled by, or
affiliated with the Chairman will in the future be determined through good
faith negotiations between the Company and such related entities, subject to
the approval of independent directors of the Company. Potential conflicts of
interests will be resolved by independent directors of the Company in the
exercise of their fiduciary duties to the Company's shareholders.
Industry Overview
The industry in which the Company operates encompasses a broad range of
business services to healthcare providers. These services include physician
fee structuring, procedure and diagnosis coding, third party and insurance
benefit verification, patient claims billing and collection and accounts
receivable management services. The Company believes that demand for these
3
<PAGE>
services has grown due to an increasingly complex reimbursement process,
downward pressure on medical fees, rapid technological changes and
processing system obsolescence and growth in hospital outpatient claims and
receivables owed by patients.
Historically, the industry has been comprised of small companies and a
limited number of national and regional companies that provide billing,
accounts receivable and other business services to hospital-affiliated
physicians. The industry presently includes numerous local companies and
several national and regional companies.
Many physicians, particularly those based in hospitals, have
traditionally used the services of outside vendors to secure reimbursement
from third party payors. Hospitals, on the other hand, have tended to rely
upon their business departments to provide most billing and accounts
receivable management functions. Producers of hospital information systems
have made this possible by designing turnkey systems that perform various
accounts receivable processing functions. Such systems have been available
to hospitals for a number of years. The Company believes that the business
of providing such services to hospitals is relatively new and that the
demand for such services should increase as hospitals continue to experience
growing accounts receivable, increasing bad debt and late payments, as well
as mounting costs of maintaining business departments capable of providing
adequate accounts receivable management services.
Services Marketed by the Company
The Company markets a broad spectrum of services to Medical Service
Providers. These services include start-up services, data accumulation and
storage, data coding, insurance and patient billing, transmission of
electronic claims and statements, establishment of write-off procedures,
application of adjustments, follow-up on insurance claims, patient inquiry
services, preparation of management reports, third-party audit support
services, establishment of collection procedures, selection of collection
agency and maintenance of operational procedures. Accounting services
include preparation and maintenance of financial books and records,
preparation of balance sheets, income statements and workpapers, and
coordination with accountants and tax preparers.
The Company enters into contracts with its clients for the provision of
services for a fee which generally is based upon percentage of net
collections and is billable monthly upon collection. The Company's fees
vary depending upon the average physician charge per procedure, number of
procedures, difficulty of collection, and payor mix (e.g., Medicare,
commercial insurer or self-pay). The fee charged by the Company generally
is fixed at the outset of the engagement based upon a complete review and
analysis of the collectibility of the client's receivables portfolio and the
anticipated costs of such collection.
The Company's typical contract with the Medical Service Providers which
are owned by, controlled by or affiliated with the Chairman is for a term of
three years and provides that: (i) the client must provide to the Company,
at the Company's sole expense, specified information and materials and the
Company will have no obligation to review or verify such information; (ii)
the Company makes no warranties whatsoever with respect to the services
provided under the contract; (iii) the client's sole and exclusive remedy if
it determines that any services provided by the Company are not being
performed in a commercially reasonable manner is to terminate the contract
in accordance with its terms; (iv) the client will indemnify the Company
under certain conditions; (v) neither the Company or its officers,
directors, stockholders, partners, employees or agents will be liable to the
client for any damages unless the client's damages are solely due to the
gross negligence or willful conduct of such party and the Company's total
maximum liability is
4
<PAGE>
$2,500 therefor, and in no event will the Company or such other parties be
liable for (a) any damages caused by the client's failure to perform its
obligations under the contract, (b) any third party claims except a claim
based on a breach of confidentiality, (c) any loss of profit, records, files
or data, (d) any delay in delivery of services or (e) any other special,
indirect, incidental or consequential damages; (vi) the Company will keep
the information and materials it receives from the client confidential;
(vii) the Company may renegotiate the terms of the contract if there is a
significant change in any law, regulation or policy which materially and
adversely affects the Company's ability to perform the contract; (viii) the
client agrees not to solicit or employ any of the Company's employees during
the term of the contract and for one year thereafter without the prior
written consent of the Company; and (ix) either party may terminate the
contract upon 90 days prior written notice to the other party, and if the
client elects to terminate the contract it must pay to the Company a
transitional consulting fee equal to the fees it paid to the Company during
the previous 180 days. The contract contains an arbitration procedure to be
followed in the event that any dispute arises between the parties under
contract.
Acquisition Strategy and Structure
The Company has acquired and intends to continue to acquire contracts
from companies which provide similar services as those marketed by the
Company and may, in the future, acquire entities that provide such services.
The Company will also attempt to acquire the service component of certain
Medical Service Providers that perform their own billing functions. While
the terms of the acquisitions will vary in certain respects, such
acquisitions are generally expected to involve the purchase of contracts at
an agreed upon price, as well as non-competition and non-solicitation
agreements between the Company and the selling entity. The purchase price
for the acquisitions will be determined, among other things, based on
projected cash flow to the Company of such contracts and will typically be
paid by combinations of cash and capital stock and, in some cases,
promissory notes. There can be no assurance that the Company can continue
to identify and acquire desirable contracts or entities on terms favorable
to the Company or in a timely manner, or that such acquisitions, if
consummated, will prove to be beneficial to the Company.
The Reimbursement Process
Medical Service Providers receive payment for medical services from
patients, third-party payors, or a combination of both. Third-party payors
include insurance companies, federal and state governments and their
intermediaries, health maintenance organizations, preferred provider
organizations, third-party administrators for self-insured companies and
other "managed care" entities. Although patients generally retain primary
payment responsibility for all medical services they receive, Medical
Service Providers typically agree to process claims through third-party
payors before requesting payment from patients for deductibles, co-payments
or any other amounts due on account of uncovered services. Most Medical
Service Providers bill patients in full or for the estimated patient
obligations at the same time they bill the third-party payor.
Obtaining reimbursement from third-party payors is becoming increasingly
difficult because of changes in reimbursement methods. Managed care
concepts such as pre-admission certification, utilization review and other
administrative procedures implemented by third-party payors in an effort to
control costs have also complicated the reimbursement process. In addition,
Medical Service Providers are increasingly unable to collect charges or
deposits of estimated net balances directly from their patients at the time
medical services are rendered. Consequently,
5
<PAGE>
Medical Service Providers often assume responsibility for obtaining
reimbursement from third-party payors.
Many third-party payors administer reimbursement claims through
locally-established operating centers or through local independent
contractors. In many cases, these third-party processing centers establish
independent formulas and procedures for processing reimbursement claims.
The Medicare program is administered by the Health Care Financing
Administration ("HCFA"), a division of the United States Department of
Health and Human Services. HCFA has established guidelines pursuant to
which claims for physician are reimbursed in accordance with a
resource-based relative value guide, the values of which vary according to
geographic location. The Medicaid program is subject to federal regulation
but is administered by state governments. State governments provide for
Medicaid claims reimbursement either through the establishment of
state-owned and operated processing centers or through contractual
arrangements with third-party administrators. The requirements and
procedures for reimbursement implemented by local Medicaid program
administrators also differ from state to state.
Similar to the claims administration process of Medicare and Medicaid,
many national health insurance companies administer reimbursement claims
through local or regional offices. Consequently, because guidelines for the
reimbursement of claims generally are established by third-party payors at
the local or regional level, reimbursement managers for Medical Service
Providers must be familiar with the local methods and procedures utilized by
various third-party payors.
Third-party payors reimburse a beneficiary, or the beneficiary's
assignee, only for services covered under the terms of the beneficiary's
health insurance policy. Typically, medical services to treat illnesses and
injuries are covered, whereas routine checkups, physicals, certain
vaccinations and other types of preventive medical care are not. Patients
and Medical Service Providers who are uncertain whether a third-party
payor's coverage limitations are applicable to a particular medical
treatment or service must either contact the payor's customer service
representative or submit a claim and wait for a determination of whether the
claim will be paid or denied.
Third-party payors also make reimbursement contingent on the
coordination of coverage with other insurance policies covering the same
beneficiary. A substantial number of patients are covered by multiple forms
of health insurance. Whether an insurance policy's coverage is primary or
secondary in payment priority to another policy often is difficult to
determine. Moreover, regular health insurance coverage often has
subrogation rights with respect to workers' compensation and automobile
insurance coverage for injuries suffered in the workplace or in automobile
accidents.
Claims submitted to third-party payors for reimbursement may be denied
or returned for many reasons. Employment changes by a beneficiary, the
delivery of noncovered services, secondary payor liability, the failure to
pre-certify or submit required information and the submission of incorrect
billing information are common examples. The significant number of
variables that can affect the administration of a claim, including numerous
possible diagnoses, treatment procedures and responsible third-party payors,
often result in multiple errors which make time-consuming corrections a
costly component of the reimbursement process.
Additionally, commercial payors and governmental reimbursement programs
engage in various types of utilization review. The purpose of utilization
review programs is to verify that
6
<PAGE>
medical services provided to patients are medically necessary and are
eligible for coverage. The utilization review process further complicates
and delays the reimbursement process.
The Company's services include interacting with all of the foregoing
reimbursement sources on behalf of its clients.
Government Regulation
Medicare laws relating to physician reimbursement directly affect the
Company's operations by, among other things, limiting the amount of
reimbursement received by the Company's clients which, in turn, reduces the
net revenues the Company can receive from its clients. On January 1, 1992,
the Federal government implemented a new fee structure known as the Resource
Based Relative Value Scale ("RBRVS") for physicians who treat Medicare
patients. As a result of the continued implementation of RBRVS, the Company
estimates that its physician clients will experience a decline in Medicare
reimbursement as a percentage of Medicare charges during 1997. Because the
Company's net revenues are based in part on receipt of a percentage of its
clients' cash receipts, an RBRVS that has the effect of reducing the amount
of reimbursement made to the Company's physician clients will reduce the
Company's net revenues correspondingly. If any additional legislative or
regulatory changes are adopted that reduce the amount of hospital-affiliated
physicians' Medicare reimbursement, the Company's net revenues are likely to
experience a corresponding reduction. In addition, the implementation of a
national health insurance program could have an adverse effect upon the
Company's operations because such a program could substantially reduce the
complexity of the healthcare reimbursement process and eliminate or
substantially reduce the demand for the Company's services.
Under Medicare, Medical Service Providers are permitted to assign
Medicare claims to billing and collection services only in certain limited
circumstances. The Company believes that its practices and procedures
regarding billing and collection services do not constitute assignment of
Medicare claims by physicians or hospitals. The Medicare statutes that
restrict assignment of Medicare claims are supplemented by Medicare
regulations and provisions in the Medicare Carrier's Manual (the "Manual").
The Medicare regulations and the Manual provide that a billing service that
prepares and sends bills for the provider or physician and does not receive
and negotiate the checks made payable to Medical Service Providers does not
violate the restrictions on assignment of Medicare claims. The Company
believes that its operations are consistent with these provisions because
the Company bills only in the name of the Medical Service Providers, checks
and payments for Medicare services are made payable to the Medical Service
Providers and the Company lacks any power, authority or ability to negotiate
checks made payable to the Medical Service Provider (i.e., monies collected
are deposited in a lock box or otherwise directly in the physician's bank
account). Therefore, the Company believes that its practices do not violate
the restrictions on assignment of Medicare claims.
The Company is also subject to criminal, civil and administrative
penalties under Federal and state law prohibitions against submitting false
claims for payments. Generally, criminal penalties subjecting participants
to fines and imprisonment require that the entity act knowingly, willfully
or with fraudulent intent. This standard might be met if an agent of the
Company prepared and filed false claims or was aware of false Claims
initiated by clients. In addition, the Company could be viewed as
conspiring to defraud Medicare or another third-party payor, or as aiding
and abetting the client in a criminal billing scheme if it were aware that
inaccurate claims were being submitted. Civil statutes provide for penalties
in excess of $10,000 per claim, including submitting claims with "reckless
disregard" of the truth or falsity of submitted information. The Federal
civil money
7
<PAGE>
penalties statute provides for civil penalties of up to $10,000 per claim
(plus an assessment of twice the amount claimed) against anyone who presents
or causes to be presented a false or improper claim under Medicare or
Medicaid, including billing agents. Liability is imposed on persons who
"know or should know" that a claim is "false," "fraudulent" or for services
"not provided as claimed." In addition, the Company is subject to various
other laws that provide for monetary sanctions for technical billing
violations, many of which may give rise to penalties of up to $10,000 per
violation. The Company is also subject to criminal laws regarding failure to
disclose known overpayments under Medicare or Medicaid.
The Social Security Act imposes criminal penalties upon persons who make
or receive kickbacks, bribes or rebates in connection with the Medicare and
Medicaid programs. These anti-kickback rules prohibit individuals and
entities from knowingly and willfully soliciting, offering, receiving or
paying, directly or indirectly, any renumeration in return for (a) referring
someone for a good, facility, service or item, (b) purchasing, leasing,
ordering or arranging for a good, facility, service or item or (c)
recommending that an individual purchase, lease or order a good, facility,
or services or item reimbursable under Medicare or Medicaid. In addition to
other penalties, violation of any of the statues described above could lead
to the exclusion from Medicare and Medicaid which would preclude its clients
from receiving reimbursement for any monies paid to the Company. Similarly,
violations of any of the statutes described above or other such activity by
an officer or a stockholder with a 5% or greater interest in the Company
which results in the exclusion of such stockholder from Medicare or Medicaid
could lead to the exclusion from the programs.
Credit collection practices and activities are regulated by both Federal
and state law. The Federal Fair Debt Collection Practices Act (the "Federal
Fair Debt Act") sets forth various provisions designed to eliminate abusive,
deceptive and unfair debt collection practices by debt collectors. The
Federal Fair Debt Act also provides for, among other things, a civil right
of action against any debt collector who fails to comply with the provisions
thereof. Various states also have promulgated laws and regulations that
govern credit collection practices. In general, these laws and regulations
prohibit fraudulent and oppressive credit collection practices and may
impose license or registration requirements upon collection agencies. State
credit collection laws and regulations typically provide for civil
penalties, injunctions, criminal fines and imprisonment for collection
agency personnel who fail to comply with such laws and regulations.
Although the Company does not provide past due or delinquent credit
collection services, the services it markets to its clients may subject it
to regulation as a "debt collector" under the Federal Fair Debt Act or as a
"collection agency" under state collection agency laws and regulations.
Management believes that the Company operates in accordance with the Federal
Fair Debt Act and complies in all material respects with the applicable
collection agency laws and regulations governing collection practices in the
states in which it conducts its business, or is exempt from such laws and
regulations.
Competition
The industry in which the Company operates is highly competitive.
Principal competitors include small physician billing and accounts
receivable management services companies, large physician groups that
provide their own reimbursement management functions, and regional and
national companies that provide billing accounts receivable management
services to hospital-affiliated physicians. In addition, the Company
competes with hospitals that offer billing and accounts receivable
management services to their affiliated physicians. To a lesser extent, the
Company also competes with producers of turnkey physician reimbursement
systems, which
8
<PAGE>
generally are purchased by large physician practice groups that manage their
own reimbursement functions and have the resources necessary to purchase,
maintain and operate such systems.
Employees
As of March 18, 1997, the Company had three employees, none of whom are
represented by a union. The Company intends to conduct its operations
utilizing only a small executive staff. The Company believes that its
relationships with its employees are good.
Important Factors Regarding Forward Looking Statements
Some of the information presented in this report constitutes forward
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Although the Company believes that its expectations are
based on reasonable assumptions within the bounds of its knowledge of its
business and operations, there can be no assurance that actual results of the
Company's marketing and acquisition activities and its results of operations
will not differ materially from its expectations. Factors which could cause
actual results to differ from expectations include, among others, uncertainty
of whether the Company's marketing activities will result in an expansion of
its client base or lead to additional acquisitions of contracts and entities,
uncertainties related to the demand for the services provided by the Company,
uncertainties related to state and federal governmental regulation of the
Company's business, and the uncertainty of whether the combination of
operating cash flows, the proceeds of the Company's initial public offering
and repayment of the note receivable will be sufficient to fund its growth
and operations over the next twelve months. Specific reference is made to the
risks and uncertainties described in the Company's Registration Statement on
Form S-3, Registration No. 333-11381, the Company's Registration Statement on
Form SB-2, Registration No. 333-00804, and the Company's Registration
Statement on Form SB-2, Registration No. 33-87266-LA.
ITEM 2. DESCRIPTION OF PROPERTY
The Company leases space for its headquarters and executive offices in
Sparks, Nevada on a month-to-month basis at a monthly rental of $300 from an
entity which is owned and controlled by the Chairman. Through February
1997, the Company also rented an office located in Newton, Massachusetts.
Under the terms of the lease, which was for a term of five years, the
Company paid a monthly rental of $5,439.50. This lease is expected to be
assigned effective March 1, 1997.
ITEM 3. LEGAL PROCEEDINGS
The Company is not presently involved in any material pending litigation
or proceeding.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
9
<PAGE>
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
The Common Stock of the Company has been listed on the Nasdaq National
Market under the symbol NMFS since January 29, 1996. Prior thereto, the
Common Stock was listed on the Nasdaq SmallCap Market. The following table
sets forth, for the periods indicated, the high and low sales prices for the
Common Stock on the Nasdaq SmallCap Market and the Nasdaq National Market (1).
1995 High Low
- ---- ---- ---
3rd Quarter (beginning August 3)..... $3.25 $2.00
4th Quarter.......................... $4.50 $2.63
1996
- ----
1st Quarter.......................... $6.63 $4.25
2nd Quarter.......................... $6.50 $3.44
3rd Quarter.......................... $5.19 $3.13
4th Quarter.......................... $4.38 $3.25
- ---------
(1) The high and low prices reported in the table have been restated to
reflect the 2 for 1 stock split which was effective on February 24, 1997.
As of March 19, 1997, there were approximately 100 record holders and
approximately 1000 beneficial owners of the Common Stock.
The Company has never declared or paid cash dividends on its Common
Stock. The Company currently intends to retain its earnings to provide funds
for the operation and expansion of its business and, therefore, does not
anticipate declaring or paying cash dividends in the foreseeable future. Any
payment of future dividends will be at the discretion of the Board of
Directors and will depend upon, among other things, the Company's earnings,
financial condition, capital requirements, level of indebtedness, contractual
restrictions with respect to the payment of dividends and other relevant
factors.
During the year ended December 31, 1996, in connection with certain
acquisitions of accounts receivable and client contracts, the Company issued
shares of Common Stock to the former owners of such accounts receivable and
client contracts as follows:
<TABLE>
<CAPTION>
Acquisition Transaction Date Number of Shares Price per Share
- ----------- ---------------- ---------------- ---------------
<S> <C> <C> <C>
Doctors Medical February 13, 1996 388,236 $4.25
National Medical April 1, 1996 60,000 $5.00
Rapier August 1, 1996 42,740 $4.56
</TABLE>
All of the issuances of Common Stock by the Company during the year ended
December 31, 1996 were made pursuant to exemptions from registration under
Section 4(2) of the Securities Act of 1933, as amended.
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
10
<PAGE>
The following discussion and analysis should be read in conjunction with
the financial statements and notes thereto included elsewhere herein.
Some of the information presented in this report constitutes forward
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Although the Company believes that its expectations are
based on reasonable assumptions within the bounds of its knowledge of its
business and operations, there can be no assurance that actual results of the
Company's activities and its results of operations will not differ materially
from its expectations. See "ITEM 1 - BUSINESS - Important Factors Regarding
Forward Looking Statements."
Overview
The Company was formed initially as a vehicle for the outsourcing of
billing, collection and accounts receivable management services, as well as
certain accounting services, which were performed internally by over 40
Medical Service Providers which are owned by, controlled by, or affiliated
with the Chairman. The Company commenced operations in August 1994 and
entered into a series of contracts commencing October 1, 1994 to provide
billing and collection services to these Medical Service Providers. Under
most of these contracts, the Company's clients pay an aggregate of 4% for
billing, collection and accounting services. These contracts expire in
September 1997 and the Company is in the process of negotiating with these
Medical Service Providers terms under which the Company will continue to
provide to these entities. There can be no assurances that the Company will
reach agreements with these entities or that such agreements, if reached,
will be on terms as favorable to the Company as the existing contracts.
Since the Company's inception, the Company has acquired certain
businesses and contracts to provide billing, collection and other services.
Upon such acquisition, the Company assumes the obligations under the
contracts then in place on their existing terms and conditions. Some of
these contracts require the clients to pay higher rates for the services
provided thereunder. In certain instances, the Company's clients pay a flat
monthly fee or annual fee for services. Regardless of the amount of fees paid
to the Company by a particular client, the Company retains its operating
margin of 30% because of its contractual relationship with Russell Data.
There can be no assurance that the Company will be able to continue to
acquire, negotiate or renew contracts on the same terms and conditions as it
has to date.
The Company expects to continue to expand its business over the next year
by marketing through direct sales to new clients, as well as acquisitions of
client contracts and acquisitions of businesses similar to the Company. In
addition to acquisitions, the Company anticipates that its principal
marketing activities for the foreseeable future will include direct sales,
attendance at trade shows, telemarketing, production of written marketing
materials and seminars. These marketing activities are currently conducted
by the Chairman and certain outside consultants.
In October 1994, the Company entered into a non-exclusive ten-year
contract with Russell Data, which is owned and controlled by the Chairman,
pursuant to which Russell Data will provide, directly or through
subcontractors, services to the Company's clients. The terms of the
agreement with Russell Data include a fee of 70 percent of net revenues
received by the Company for services billed by Russell Data. Because the
Company will rely primarily on Russell Data for the performance of a
substantial amount of the Company's services, the Company expects that it
will require a minimal number of employees and equipment over the next twelve
months.
In January 1995, the Company decided to expand its services to be
marketed to include accounting services to Medical Service Providers. The
Company entered into a series of contracts
11
<PAGE>
to provide this new service to the Medical Service Providers which are owned
by, controlled by, or affiliated with the Chairman. The Company may in the
future further expand the services it markets to its customers or acquire
contracts or businesses in other medical or non-medical industries, but there
is no assurance that will do so.
There are a number of trends and uncertainties which may have a material
adverse effect on the Company in the future. The Company's clients are
subject to extensive federal, state and local legislation with respect to
many aspects of their operation. It can be expected that statutes and
regulations to which these clients are subject, which have been substantially
modified during recent years, will continue to be modified in the future.
Various proposals affecting federal and state regulations of the healthcare
industry, including limitations on Medicare reimbursements and limitations on
referrals, have been introduced. Management cannot predict what effect such
legislation will have on the operations of the Company.
Results of Operations
Year Ended December 31, 1996 Compared to Year Ended December 31, 1995
During 1995, the Company consummated one acquisition of a billing and
collection company and one acquisition of a billing contract. During 1996,
the Company consummated three separate transactions in which it acquired
approximately 52 billing contracts.
Total revenues for the years ended December 31, 1996 and 1995 were
$9,215,117 and $5,956,029, respectively, an increase of approximately 54.7%.
Approximately 49.9% of the 1996 revenues, as compared to 85.1% of the 1995
revenues, were derived from the Company's contracts with Medical Service
Providers owned by, controlled by, or affiliated with the Chairman. The
acquisitions made by the Company during the second and fourth quarters of
1995 and the acquisitions made in the first, second and third quarters of
1996 are the primary reasons for the increased volumes. Revenues earned for
the year ended December 31, 1996 consisted of $8,343,288, or 90.5% of
revenues, for billing and collections services, $558,462, or 6.1% of
revenues, for accounting services, and $194,495, or 2.1% of revenues, for
late charges, and $118,872, or 1.3% of revenues, for consulting services.
Revenues earned for the year ended December 31, 1995 consisted of $5,068,243,
or 85.1% of revenues, for billing and collections services, $641,417, or
10.8% of revenues, for accounting services, and $246,369, or 4.1% of
revenues, for late charges. The percentage of revenues attributable to
billing and collection services as compared to accounting services has
increased as the Company has acquired additional contracts which provide only
for billing and collection services.
During the years ended December 31, 1996 and 1995, the Company incurred
costs to Russell Data in the amount of $6,222,988 and $3,996,663,
respectively, for services rendered. The Company reported operating income
of $2,992,129, income before taxes of $2,092,562, net income of $1,405,462,
and primary earnings per share of $0.09 for the year ended December 31, 1996.
The Company reported operating income of $1,959,366, income before taxes of
$1,365,003, net income of $891,703, and primary earnings per share of $0.08
for the year ended December 31, 1995.
The Company incurred selling, general and administrative expenses of
$1,256,731 and $723,516 for the years ended December 31, 1996 and 1995,
respectively. The expenses for 1996 consisted primarily of amortization of
client contracts, salaries and related employee benefits,
12
<PAGE>
franchise taxes and professional fees, while the expenses for 1995 consisted
primarily of salaries and related employee benefits and professional fees.
The Company's effective tax rate was 32.8% and 34.7% for the years ended
December 31, 1996 and 1995, respectively.
Year Ended December 31, 1995 Compared to Year Ended December 31, 1994
Since the Company was formed on August 3, 1994 and contracts were
executed commencing on October 1, 1994, the results of operations for the
year ended December 31, 1994 reflect only start-up expenses and three months
of operations. The results of operations for the year ended December 31, 1995
reflect a full year of operating results. These results also reflect a lower
percentage fee when compared to 1994, which lower percentage fee was
negotiated by the Company and certain Medical Service Providers effective
January 1, 1995. During 1995, the Company consummated one acquisition of a
billing and collection company and one acquisition of a billing contract.
Total revenues for the years ended December 31, 1995 and 1994 were
$5,956,029 and $2,330,757, respectively, an increase of approximately 155.5%.
Substantially all of the revenues were derived from the Company's contracts
with Medical Service Providers owned by, controlled by, or affiliated with the
Chairman. Effective January 1, 1995, the Company began providing accounting
services to these Medical Service Providers pursuant to amendments to the
existing contracts with these Medical Service Providers. Russell Data
provides accounting services to the Company in exchange for 70 percent of net
revenues to be received by the Company for services billed by Russell Data.
Additionally, the billing and collection contracts with the Medical Service
Providers were modified to a substantially lower percentage of revenues to be
earned by the Company. On June 30, 1995 and December 1, 1995, the Company
acquired the assets of Asterino and a billing contract of Rapier,
respectively. The acquisitions were recorded using the purchase method of
accounting. The effects of the acquisitions were to record the
Asterino-related revenues starting July 1, 1995 and the Rapier-related
revenues starting December 1, 1995. Revenues earned for the year ended
December 31, 1995 were $5,068,243, or 85.1% of revenues, for billing and
collections services, $641,417, or 10.8% of revenues, for accounting
services, and $246,369, or 4.1% of revenues, for late charges. Revenues
earned for the year ended December 31, 1994 were exclusively for billing and
collections services.
During the years ended December 31, 1995 and 1994, the Company paid
Russell Data $3,996,663 and $1,631,530, respectively, for services rendered.
The Company reported operating income of $1,959,366, income before taxes of
$1,365,003, net income of $891,703, and primary earnings per share of $0.08
for the year ended December 31, 1995. The Company reported operating income
of $699,227, income before taxes of $520,295, net income of $303,195 and
primary earnings per share of $0.03 for the year ended December 31, 1994.
The Company incurred selling, general and administrative expenses of
$723,516 and $178,932 for the years ended December 31, 1995 and 1994,
respectively. These expenses consisted primarily of salaries and related
employee benefits, professional fees and travel for both periods.
The Company's effective tax rate was 34.7% and 41.7% for the years ended
December 31, 1995 and 1994, respectively. The Company incurred federal
income taxes of $217,100 for the period August 3, 1994 through December 31,
1994. Since the Company elected
13
<PAGE>
to be treated as a Subchapter S corporation through November 30, 1994, income
taxes were recognized in the amount of $141,000 to reflect the difference
between the net operating loss of the Subchapter S corporation on a cash
basis and the accrual basis accounting for the C corporation.
Liquidity and Capital Resources
At inception, the Company's operations were funded by $1,000,000 in
capital contributions in the form of notes received from the Company's
principal stockholders, which notes have been repaid. In addition, the
Company realized net income from operations of $1,405,462 and $891,703 for
the years ended December 31, 1996 and 1995, respectively.
In June 1995, the Company acquired the cash, accounts receivable and the
client contracts of Asterino, a billing and collection company located in
Schenectady, New York that provides services to approximately 20 Medical
Service Providers who were not affiliated with Asterino or the Chairman. The
total consideration paid for the acquisition was $1,050,000 in cash and
$600,000 in Common Stock valued at the Company's initial public offering
price, or 300,000 shares. These shares are freely tradable, subject to a
lock-up agreement which expired on January 1, 1997. An additional 5,000
shares in lieu of interest were issued on October 1, 1995 in connection with
this transaction. The Company placed an additional 200,000 shares of Common
Stock into escrow pursuant to the purchase agreement. Fewer shares will
ultimately be released from escrow if certain revenue levels are not
maintained.
On August 9, 1995, the Company completed its initial public offering (the
"Offering") of 4,000,000 shares of Common Stock at $2.00 per share. In
addition, the underwriters exercised in full their over-allotment of 600,000
shares in full on August 21, 1995. The net proceeds to the Company of its
Offering and the exercise of the over-allotment option was approximately
$7,550,000.
On December 1, 1995, the Company acquired a billing contract between
Rapier and UEMF. The total consideration paid for the contract was $750,000,
consisting of $650,000 in cash and 27,118 shares of Common Stock valued at
$3.69 per share, the price of the Common Stock on December 1, 1995. In
accordance to the purchase agreement, the Company placed these shares into
escrow. Fewer shares may be released from escrow if certain revenue levels
are not maintained.
On February 13, 1996, the Company acquired the accounts receivable and
client contracts from Doctors Medical. The total consideration paid for this
acquisition was $1,800,000, consisting of $150,000 in cash and 388,236 shares
of Common Stock valued at $4.25 per share. In accordance with the purchase
agreement, the Company placed these shares into escrow. Fewer shares will
ultimately be released from escrow if certain revenue levels are not
maintained.
On April 1, 1996, the Company acquired the accounts receivable and client
contracts from National Medical. The total consideration paid for this
acquisition was $550,000, consisting of $250,000 in cash and 60,000 shares of
Common Stock valued at $5.00 per share. In accordance with the purchase
agreement, the Company placed these shares into escrow. Fewer shares will
ultimately be released from escrow if certain revenue levels are not
maintained.
On August 1, 1996, the Company acquired from Rapier seven additional
contracts to provide billing, collection and accounts receivable management
services to Medical Service
14
<PAGE>
Providers in Massachusetts and New Hampshire. The total consideration paid
was $945,000, consisting of $750,000 in cash and 42,740 shares of Common
Stock valued at $4.56 per share. In accordance with the purchase
agreement, the Company placed these shares into escrow. Fewer shares will
ultimately be released from escrow if certain revenue levels are not
maintained.
On March 1, 1997, the Company acquired a contract to provide billing and
collection services to Medical Service Providers in Rhode Island. The total
consideration paid was $164,998, consisting of $100,000 in cash and 14,444
shares of Common Stock valued at $4.50 per share. In accordance with the
purchase agreement, the Company placed these shares into escrow. Fewer
shares will ultimately be released from escrow if certain revenue levels are
not maintained.
On March 1, 1997, the Company acquired a contract to provide billing and
collection services to Medical Service Providers in the Cleveland, Ohio area.
The total consideration paid was $499,998, consisting of $300,000 in cash and
44,444 shares of Common Stock valued at $4.50 per share. In accordance
with the purchase agreement, the Company placed these shares into escrow.
Fewer shares will ultimately be released from escrow if certain revenue
levels are not maintained.
On May 1, 1996, the Company entered into a transaction with First United
Equities Corporation ("First United"), a broker-dealer registered with the
Securities and Exchange Commission. First United is the principal market
maker in the Company's common stock. Pursuant to the transaction, the
Company loaned $5,200,000 in a series of advances evidenced by a promissory
note bearing interest at 10%. Such note was due on demand with seven days
notice. The note was collateralized by the guarantees of the principals of
First United. On May 29, 1996, First United repaid $2,000,000 to the
Company. Effective October 1, 1996, the remaining balance of the note and
accrued interest was satisfied through the establishment of an unsecured note
due from Russell Data in the amount of $3,344,174. The note bears interest
at 10% and establishes a payment schedule which will result in the balance
and accrued interest being paid in full by September 15, 1997. On February
10, 1996, the Company received $1,104,786 of principal and accrued interest
from Russell Data representing the first in the series of scheduled payments.
As of December 31, 1996 and 1995, certain of the Medical Service
Providers, which are owned by, controlled by, or affiliated with the
Chairman, owed the Company approximately $362,300 and $1.8 million,
respectively, in fees for services. Since December 31, 1996, an additional
$775,600 has been billed to these entities, and the Company has received
approximately $309,000 related to the amounts. As of March 31, 1997 and
1996, $1,326,000 and $330,000, respectively, has been prepaid to Russell Data.
The Company's principal sources of liquidity are anticipated to be cash
flow from operations, proceeds from the Offering and repayment of the note
receivable. The Company expects to fund future acquisitions of contracts and
future acquisitions of businesses by a combination of funds available through
the cash from operations, proceeds from the Offering, repayment of the note
receivable and the issuance of Common Stock and promissory notes. A similar
funding strategy is anticipated to be used in its future business growth.
The Company anticipates the cash flow from operations, the proceeds of the
Offering and repayment of the note receivable will be adequate to fund its
operations for the next twelve months, although there can be no assurances to
that effect.
15
<PAGE>
Impact of Inflation and Changing Prices
To date, the Company's business has not been significantly affected by
inflation. A substantial portion of the Company's revenues are derived from
commercial insurance and government reimbursement programs, both of which
have experienced cost containment measures designed to limit payments made to
healthcare providers such as the clients of the Company. Continued cost
containment efforts by commercial and government insurers may have a material
adverse effect on the Company. The recently implemented RBRVS payment system
has reduced Medicare reimbursement rates for certain procedures of the
Company's clients. Future implementation of such a system with respect to
third party payors, which has been advocated, would adversely affect the
Company's revenues.
Prospective Accounting Changes
In March 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards ("SFAS") No. 128 "Earnings Per Share." This
Statement established standards for computing and presenting earnings per
share ("EPS") and applies to entities with publicly held common stock or
potential common stock. This Statement is effective for financial statements
issued for periods ending after December 15, 1997, earlier application is not
permitted. This Statement requires restatement of all prior-period EPS data
presented. The Company is currently evaluating the impact, if any, that the
adoption of SFAB No. 128 will have on its financial statements.
ITEM 7. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The financial statements and supplementary data required by Item 7 are
set forth following Item 13 of this Form 10-KSB.
ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
None.
16
<PAGE>
PART III
The information called for by Item 9, Directors, Executive Officers of
the Registrant, Promoters and Control Persons; Compliance with Section 16(a)
of the Exchange Act; Item 10, Executive Compensation; Item 11, Security
Ownership of Certain Beneficial Owners and Management; and Item 12, Certain
Relationships and Related Transactions, is incorporated herein by reference
to the Registrant's definitive Proxy Statement for its Annual Meeting of
Stockholders, which will be filed with the Securities and Exchange Commission
within 120 days from the end of the Registrant's fiscal year.
ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits. Unless otherwise noted, the exhibit was filed as an
exhibit to the Company's Registration Statement on Form SB-2 (File No.
33-87266-LA).
Exhibit No.
3.1 Amended and Restated Articles of Incorporation of the Company.
3.2 By-laws of the Company.
4.1 Form of certificate evidencing Common Stock of the Company.
10.1 Stock Option Plan.
10.2 Form of Agreement between the Company and its clients, as amended.
10.3 Agreement between Russell Data and the Company dated October 1, 1994,
as amended.
10.4 Lease Agreement for premises located at 1137 Financial Boulevard,
Reno, Nevada, dated August 3, 1994 between the Company and Intellisott
Systems, Inc.
10.5 Warrant Agreement between the Company and Douglas R. Colkitt, M.D.
10.6 Employment Agreement between the Company and Alan H.L. Carr-Locke,
effective June 1, 1995.
10.7 Contract Rights Purchase Agreement with Asterino & Associates, Inc.,
as amended.
10.8 Software License Agreement between Astute Systems. Inc. and the
Company, as amended.*
10.9 Contract Rights Purchase Agreement with Doctors Medical Billing
Service, dated February 13, 1996.**
10.10 Contract Rights Purchase Agreement with Rapier Investments
Limited.
17
<PAGE>
10.11 Office Lease for premises located at 7-57 Wells Avenue, Newton,
Massachusetts, dated March 12, 1996 between the Company and
Saraceno Holding Trust.
10.12 Promissory Note dated October 1, 1996 between the Company and
Russell Data Services, Inc.*
11.1 Statement re: Computation of Per Share Earnings for the Years
Ended December 31, 1996 and 1995.*
23.1 Consent of Coopers & Lybrand L.L.P.*
27.1 Statement re: Financial Data Schedule.*
* Filed herewith.
** Incorporated by reference to Exhibit 10.1 to the Registrant's Form 8-K
filed February 13, 1996.
(b) Forms 8-K
No reports on Form 8-K were filed during the last quarter of the
fiscal year ended December 31, 1996.
18
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
INDEX TO FINANCIAL STATEMENTS
Report of Independent Accountants F-2
Balance Sheets, December 31, 1996 and 1995 F-3
Income Statements for the years ended December 31, 1996 and 1995 F-4
Statement of Changes in Stockholders' Equity for the years ended
December 31, 1996 and 1995 F-5
Statements of Cash Flows for the years ended December 31, 1996 and 1995 F-6
Notes to Financial Statements F-8
F-1
<PAGE>
REPORT OF INDEPENDENT ACCOUNTANTS
To the Board of Directors
National Medical Financial Services Corporation
We have audited the accompanying balance sheets of National Medical Financial
Services Corporation as of December 31, 1996 and 1995 and the related
statements of income, changes in stockholders' equity, and cash flows for the
years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in acordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free
of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements.
An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
The Company has had certain transactions with related parties as more fully
described in the notes to the financial statements.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of National Medical Financial
Services Corporation as of December 31, 1996 and 1995 and the results of its
operations, changes in stockholders' equity, and cash flows for the years
then ended, in conformity with generally accepted accounting principles.
COOPERS & LYBRAND L.L.P.
2400 Eleven Penn Center
Philadelphia, Pennsylvania
February 26, 1997
F-2
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
BALANCE SHEETS
December 31, 1996 and 1995
<TABLE>
<CAPTION>
1996 1995
------------- -------------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents................................... $ 2,882,035 $ 6,580,223
Accounts receivable......................................... 2,339,093 2,282,051
Notes and interest receivable--related party................ 3,428,244 ---
Other assets and prepaid expenses........................... 301,738 5,218
------------- -------------
Total current assets...................................... 8,951,110 8,867,492
------------- -------------
Property and equipment, net................................... 19,118 14,232
Intangible assets, net........................................ 5,780,397 3,076,195
Deferred costs and other assets............................... 800,450 20,810
------------- -------------
Total assets.............................................. $ 15,551,075 $ 11,978,729
------------- -------------
------------- -------------
LIABILITIES
Current liabilities:
Accrued subcontract fees..................................... $ 1,074,100 $ 1,051,895
Accounts payable and accrued expenses........................ 137,880 572,252
Short term debt.............................................. 77,033
Federal income taxes payable................................. --- 135,612
------------- -------------
Total current liabilities.................................. 1,289,013 1,759,759
------------- -------------
Commitments and contingent liabilities.........................
--- ---
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value, 1,000,000 shares authorized,
none outstanding.............................................
--- ---
Common stock, $.01 par value, 40,000,000 shares authorized,
14,956,428 and 14,238,334 shares issued and outstanding...... 149,564 142,384
Paid-in capital................................................ 11,512,138 8,881,688
Retained earnings.............................................. 2,600,360 1,194,898
------------- -------------
Total stockholders' equity................................. 14,262,062 10,218,970
------------- -------------
Total liabilities and stockholders' equity................. $ 15,551,075 $ 11,978,729
------------- -------------
------------- -------------
</TABLE>
See accompanying notes to financial statements.
F-3
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
INCOME STATEMENTS
For the Years Ended December 31, 1996 and 1995
<TABLE>
<CAPTION>
1996 1995
------------ ------------
<S> <C> <C>
Revenues.......................................................... $ 9,215,117 $ 5,956,029
Subcontract expense............................................... 6,222,988 3,996,663
----------- -----------
Operating Income............................................... 2,992,129 1,959,366
Selling, general and administrative expense....................... 1,256,731 723,516
Interest (income)................................................. (360,357) (139,153)
Interest expense.................................................. 3,193 10,000
------------ ------------
Income before income taxes........................................ 2,092,562 1,365,003
Provision for income taxes........................................ 687,100 473,300
------------ ------------
Net income..................................................... $ 1,405,462 $ 891,703
------------ ------------
------------ ------------
Primary net income per share...................................... $ 0.09 $ 0.08
------------ ------------
------------ ------------
Weighted average number of shares outstanding used in primary
calculation..................................................... 15,597,264 11,502,996
------------ ------------
------------ ------------
Fully diluted net income per share................................ $ 0.09 $ 0.08
------------ ------------
------------ ------------
Weighted average number of shares outstanding used in fully
diluted calculation............................................. 15,597,264 11,628,530
------------ ------------
------------ ------------
</TABLE>
See accompanying notes to financial statements.
F-4
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
For the Years Ended December 31, 1996 and 1995
<TABLE>
<CAPTION>
TOTAL
PREFERRED SHARES OF COMMON PAID-IN RETAINED STOCKHOLDERS' STOCKHOLDERS'
STOCK COMMON STOCK STOCK CAPITAL EARNINGS RECEIVABLE EQUITY
--------- ------------ ------ ------- -------- ------------- -------------
<S> <C> <C> <C> <C> <C> <C> <C>
Balance,
January 1, 1995.... -- 9,333,334 $ 93,334 $ 906,666 $ 303,195 $(231,250) $ 1,071,945
Collection of
stockholders'
receivable.. 231,250 231,250
Issuance of common
stock... 4,600,000 46,000 7,368,072 7,414,072
Common stock issued
to acquire business.. 305,000 3,050 606,950 610,000
Net income.. 891,703 891,703
------ ----------- -------- ---------- --------- -------- ----------
Balance,
December 31, 1995... -- 14,238,334 142,384 8,881,688 1,194,898 -- 10,218,970
Common stock issued
to acquire business 718,094 7,180 2,630,450 2,637,630
Net Income.. 1,405,462 1,405,462
------ ---------- -------- --------- ---------- -------- ----------
Balance,
December 31, 1996 -- 14,956,428 $149,564 $11,512,138 $2,600,360 $ -- $14,262,062
------ ---------- ------- ---------- --------- -------- ----------
------ ---------- ------- ---------- --------- -------- ----------
</TABLE>
See accompanying notes to financial statements.
F-5
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 1996 and 1995
<TABLE>
<CAPTION>
1996 1995
------------- -----------
<S> <C> <C>
Cash flow from operating activities:
Net income.................................................................... $ 1,405,462 $ 891,703
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization expense........................................ 325,647 57,123
Insurance in lieu of cash.................................................... 53,812 --
Interest paid in stock....................................................... -- 10,000
Changes in assets and liabilities:
(Increase) decrease in receivables.......................................... 304,844 (457,984)
Increase in other assets.................................................... (272,971) (3,050)
Decrease in accounts payable and accrued expenses........................... 87,833 (1,807)
Decrease in payable to stockholder.......................................... -- (5,000)
Decrease in income taxes payable............................................ (135,612) (81,488)
------------- -----------
Net cash provided by operations.............................................. 1,769,015 409,497
------------- -----------
Cash flow from investing activities:
Receivables acquired in acquisitions.......................................... (361,886) (231,000)
Issuance of notes receivable.................................................. (5,344,174) --
Principal collections of notes receivable..................................... 2,000,000 --
Deferred costs-contract acquisitions.......................................... (768,761) (20,810)
Purchase of property and equipment............................................ (8,913) (14,565)
Software license.............................................................. -- (700,000)
Client lists.................................................................. (880,824) (1,332,086)
Other assets.................................................................. (10,879) --
------------- -----------
Net cash used in investing activities........................................ (5,375,437) (2,298,461)
------------- -----------
Cash flow from financing activities:
Proceeds from sale of stock................................................... -- 8,200,000
Initial public offering costs................................................. (7,370) (680,888)
Collection of stockholder's receivables....................................... -- 231,250
Payments of short term debt................................................... (84,396) --
------------- -----------
Net cash provided by (used in) financing activities.......................... (91,766) 7,750,362
-------------- -----------
Net increase (decrease) in cash.............................................. $( 3,698,188) $ 5,861,398
</TABLE>
See accompanying notes to financial statements.
F-6
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 1996 and 1995
<TABLE>
<CAPTION>
1996 1995
------------- ------------
<S> <C> <C>
Net increase (decrease) in cash................................ ($ 3,698,188) $ 5,861,398
Cash balance, Beginning balance.................................. 6,580,223 718,825
------------- ------------
Cash balance, Ending balance..................................... $ 2,882,035 $ 6,580,223
------------- ------------
------------- ------------
Supplemental data:
Cash paid for income taxes...................................... $ 1,101,128 $ 632,688
------------- ------------
------------- ------------
Cash paid for interest.......................................... $ 3,193 $ --
------------- ------------
------------- ------------
Non-cash items:
Stock issued for business and contract acquisitions............ $ 2,645,000 $ 600,000
------------- ------------
------------- ------------
Stock payable for business and contract acquisitions........... $ -- $ 500,000
------------- ------------
------------- ------------
Stock issued in lieu of interest............................... $ -- $ 10,000
------------- ------------
------------- ------------
Short term debt issued in lieu of insurance.................... $ 161,429 $ --
------------- ------------
------------- ------------
Note receivable issued in lieu of interest..................... $ 144,174 $ ---
------------- ------------
------------- ------------
</TABLE>
See accompanying notes to financial statements.
F-7
<PAGE>
NATIONAL MEDICAL FINANCIAL SERVICES CORPORATION
NOTES TO THE FINANCIAL STATEMENTS
1. DESCRIPTION OF BUSINESS:
National Medical Financial Services Corporation (the "Company") was
incorporated in August 1994. The Company markets billing, accounts receivable
and collections services, as well as certain accounting services to medical
providers.
The Company obtains business through marketing of its services to medical
providers and acquisition of existing contracts from other businesses
currently offering billing, accounts receivable and collection services.
There may be some instances whereby, the Company will enter into a management
contract to provide these services.
Effective October 1, 1994, the Company has contracted with Russell Data
Services, Inc. ("RDS"), to provide billing, accounts receivable and
collection services for the clients of the Company. The contract provides for
the Company to pay RDS 70% of all revenues collected by the Company for the
performance of such services. RDS is owned and controlled by the Chairman and
principal stockholder of the Company. For the years ended December 31, 1996
and 1995, all subcontract expenses are to this related party.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
REVENUE RECOGNITION:
Fees for the Company's services are primarily based on a percentage of
net collections on patient accounts, and revenue is recognized as such
services are performed. Accounts receivable represents amounts invoiced to
clients for services and late payment fees. Accounts receivable-unbilled
represents fees which will be realized upon collection of billing services
already rendered but not yet invoiced.
Cash and Cash Equivalents:
Cash and cash equivalents include all highly liquid investments with an
initial maturity of not more than three months.
Property and Equipment:
Property and equipment is stated at cost. Depreciation is computed using
the straight-line method over the estimated useful lives of the assets,
generally seven years for furniture and fixtures and five years for data
processing equipment.
Income Taxes:
Deferred tax assets and liabilities are recognized for the expected
future tax consequences of events that have been included in the financial
statements or income tax returns. Deferred tax assets and liabilities are
determined based upon the difference between the financial statements and tax
bases of assets and liabilities using enacted rates expected to apply to
taxable income in the years in which those differences are expected to be
recovered or settled. The effect on deferred tax assets and liabilities of a
change in tax rates is recognized in the period that includes the enactment
date.
F-8
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, DEFERRED TAXES, Continued:
Intangible Assets:
Intangible assets are composed of client lists and software license.
Intangible assets are amortized using the straight-line method over their
estimated useful lives of fifteen and ten years, respectively. The software
license estimated useful life is being amortized over the life of the license
and its cost includes any updates and software changes over this time period.
In the event that facts and circumstances indicate the value of intangible
assets or other assets may be impaired, an evaluation of recoverability would
be performed to determine whether an adjustment to the carrying value is
required.
SFAS 121 Disclosure:
Statement of Financial Accounting Standards 121, "Accounting for the
Impairment of Long-Lived Assets and Assets to be Disposed," ("SFAS #121")
requires that long-lived assets be reviewed for impairment whenever events or
changes in circumstances indicate that the carrying amount of the asset in
question may not be recoverable. SFAS #121 was adopted in 1996 and did not
have a material effect on the Company's results of operations, cash flows or
financial position.
Net Income Per Common Share:
Primary income per common share is calculated using the weighted average
number of common shares outstanding during the period plus (in periods in
which they have a dilutive effect) the additional number of shares which
would be issuable upon the exercise of stock options, assuming that the
Company used the proceeds received to purchase additional shares at the
stock's average market price for the period. The fully-diluted computation
reflects additional dilution related to stock options due to the use of the
market price at the end of the period, which are higher than the average
price for the period.
Prospective Accounting Changes:
In March 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards ("SFAS") No. 128 "Earnings Per Share." This
Statement establishes standards for computing and presenting earnings per
share ("EPS") and applies to entities with publicly held common stock or
potential common stock. This Statement is effective for financial statements
issued for periods ending after December 15, 1997, earlier application is not
permitted. This Statement requires restatement of all prior-period EPS data
presented. The Company is currently evaluating the impact, if any, that the
adoption of SFAS No. 128 will have on its financial statements.
Use of Estimates in the Preparation of Financial Statements:
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amount of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Management is not aware of any situations or set of circumstances existing as
of the issuance of the financial statements that, in the near-term, will
materially change estimates used in the preparation of the financial
statements as of December 31, 1996.
Reclassifications:
Certain items in the 1995 financial statements have been reclassified to
conform with the 1996 presentation.
3. ACCOUNTS RECEIVABLE:
Accounts receivables consisted of the following at December 31:
F-9
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
3. ACCOUNTS RECEIVABLE, continued:
<TABLE>
<CAPTION>
1996 1995
---------- ----------
<S> <C> <C>
Accounts receivable--billed....................................... $1,740,908 $2,020,862
Accounts receivable--unbilled..................................... 592,886 231,000
Miscellaneous receivable......................................... 5,299 30,189
---------- ----------
Total............................................................. $2,339,093 $2,282,051
---------- ----------
---------- ----------
</TABLE>
4. NOTES RECEIVABLE:
On May 1, 1996, the Company entered into a transaction with First United
Equities Corporation ("First United"), a broker-dealer registered with the
Securities and Exchange Commission. First United is the principal market
maker in the Company's Common Stock. Pursuant to the transaction, the Company
loaned $5,200,000 through a series of advances evidenced by a promissory note
bearing interest at 10%. Such note was due and payable on demand with seven
days notice. The note was collateralized by the guarantees of the principals
of First United. On May 29, 1996, First United repaid $2,000,000 to the
Company. Effective October 1, 1996, the remaining balance of the note and
accrued interest was satisfied through the establishment of an unsecured note
due from Russell Data Services, Inc., a Nevada corporation which is owned by
the Company's Chairman and principal stockholder ("RDS"), in the amount of
$3,344,174. The note bears interest at 10% and establishes a payment schedule
of $1,000,000 each at January 15, April 15 and July 15, 1997 plus interest
thereon with the remaining balance and interest thereon due on September 15,
1997. On February 10, 1997, the Company received $1,104,786 in principal and
accrued interest from RDS in accordance with the payment schedule.
5. PROPERTY AND EQUIPMENT:
Property and equipment consists of the following at December 31:
<TABLE>
<CAPTION>
1996 1995
------- -------
<S> <C> <C>
Furniture and fixtures.................................................. $ 4,151 $ 2,192
Office equipment........................................................ 20,277 13,318
------- -------
24,428 15,510
Less accumulated amortization........................................... (5,310) (1,278)
------- -------
$19,118 $14,232
--------- ---------
--------- ---------
</TABLE>
6. INTANGIBLE ASSETS:
Intangible assets consists of the following at December 31:
<TABLE>
<CAPTION>
1996 1995
------------ ------------
<S> <C> <C>
Client lists...................................................... $5,457,911 $2,432,087
Software license.................................................. 700,000 700,000
--------- ---------
6,157,911 3,132,087
Less accumulated amortization..................................... (377,514) (55,892)
--------- ---------
$5,780,397 $3,076,195
--------- ---------
--------- ---------
</TABLE>
F-10
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
6. INTANGIBLE ASSETS, continued:
In January 1995, the Company made a refundable deposit of $700,000 for an
unlimited site software license for a maximization of reimbursement software
program. The program was installed on December 1996. The software has a ten
year licensing period which includes all up-dates and software changes. The
Company has adopted the straight-line method of amortization over the ten
year period. The software company is owned and controlled by the Chairman and
principal stockholder of the Company.
7. LEASE COMMITMENTS:
The Company leased office space under a noncancelable operating lease,
which expired in April 1996. Upon its expiration, the Company obtained
additional office space and entered into a new noncancellable operating lease
which expires in March 2001. Rental expense for the years ended December 31,
1996 and 1995 was $50,588 and $21,216, respectively. Future minimum lease
payments under noncancelable operating leases as of December 31, 1996 are as
follows:
1997............ $ 65,274
1998............ 65,274
1999............ 65,274
2000............ 65,274
2001............ 16,319
---------
$277,415
---------
---------
The Company has entered into a month-to-month operating lease for office
space from an entity that is owned and controlled by the Chairman and
principal stockholder of the Company. The monthly rental of $300 includes
utilities. For the years ended December 31, 1996 and 1995, the Company
incurred rental expense of $3,600, respectively, pursuant to this lease.
8. SHORT TERM DEBT:
Short term debt consists of a note payable agreement for the annual
premiums of the Company's Directors and Officers Liability insurance policy
entered into on August 1996. The amount financed ($137,215) under the note
agreement consists of nine monthly payments of $15,648 including interest at
6.28%. The Company incurred interest expense in 1996 of $3,193 relating to
this instrument.
9. COMMON STOCK, OPTIONS AND WARRANTS:
In September 1996, the Company registered, on Form S-3, 9,333,334 shares
of Common Stock which are owned by certain stockholders of the Company,
including 7,341,666 shares which are owned by the Chairman and principal
stockholder of the Company.
F-11
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
9. COMMON STOCK, OPTIONS AND WARANTS, continued:
On May 10, 1996 (the "Effective Date"), the Board of Directors approved a
Stock Option Plan for Non-Employee Directors (the "Plan"). The Plan provides
for options to purchase up to 1,000,000 shares of common stock, which may be
granted to non-employee directors. Under the terms of the Plan each
non-employee director of the Company will automatically be granted, on the
date of the Company's annual meeting of stockholders each year during the
term of the plan, options to purchase 50,000 shares. The option exercise
price will be the fair market value of a share of the Company's Common Stock
on the date of grant. The options will become exercisable six months after
the date of grant and will expire ten years after the date of grant. In
addition, on the Effective Date, each of the three eligible directors (other
than the Chairman) were granted stock options to purchase 100,000 shares of
Common Stock at an exercise price equal the fair market value on the day of
grant (or $5.10). The Plan was presented and approved by the stockholders
at the Company's 1996 Annual Meeting of Stockholders. On June 25, 1996, each
of the four eligible directors (including the Chairman) were granted stock
options to purchase 50,000 shares of Common Stock at an exercise price of
$4.28, the fair market value on the day of grant. At December 31, 1996,
options for 500,000 shares, are outstanding under the plan, at exercise
prices ranging from $4.28 to $5.10 per share. No shares were exercised during
1996.
On August 3, 1995, the Company granted the President and CEO of the
Company stock options to purchase 1,041,666 shares of common stock at an
exercise price of $2.25 which became exercisable on August 3, 1996. At the
date of grant, the exercise price of the stock of $2.25 exceeded the market
price of $2.00.
The Company instituted a stock option plan whereby directors and key
employees of and/or consultants to the Company can receive incentive stock
options and non-qualified stock options to purchase up to an aggregate of
600,000 shares of the Company's common stock. During 1995, the Company
granted non-qualified options to acquire 193,824 shares of stock at the fair
market value on the date of grant ($4.31), and incentive options to acquire
46,376 shares of stock at 110% of the fair market value on the date of grant
($4.74). The incentive and non-qualified options will expire in five and
ten years, respectively, from the date of grant. No additional grants covered
by this plan were awarded in 1996. At December 31, 1996 and 1995, options for
240,000 shares, respectively, are outstanding under the plan, at exercise
prices ranging from $4.31 to $4.74 per share. No shares were exercised
during 1996 and 1995.
In December 1994, the Company granted to the Chairman of the Company
warrants to purchase a total of 6,000,000 shares of common stock at exercise
prices ranging from $7.50 to $12.50. The warrants are in 2,000,000 share
increments and expire on August 3, 1998, 2000, and 2002. As of December 31,
1996 and 1995, none of the warrants has been exercised.
In connection with its initial public offering, the Company issued
warrants to purchase 400,000 shares of common stock to its Underwriters. The
shares of common stock subject to the Underwriter's Warrants are identical to
the shares sold to the public except for the purchase price and certain
registration rights. The Underwriter's Warrants will be exercisable for a
four-year period commencing one year from the date of the initial public
offering at an exercise price of $3.00 per share. No shares were exercised
during 1996.
F-12
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
9. COMON STOCK, OPTIONS AND WARRANTS, continued:
As of December 31, 1996 and 1995, the Company has one and two fixed
options plans, respectively. Under the Stock Option Plan ("SOP"), the Company
may grant incentive and non-qualified stock options to its directors and key
employees of and/or consultants to the Company for up to an aggregate of
600,000 shares of the common stock. Under the Stock Option Plan for
Non-Employee Directors ("SOPNED"), the Company may grant options to its
non-employee directors for up to an aggregate of 1,000,000 shares of common
stock. Under both plans, the exercise price of each option equals the fair
market value of a share of the Company's Common Stock on the date of grant.
The options issued under the SOP will expire five or ten years after the date
of grant. The options issued under the SOPNED will become exercisable six
months after the date of grant and will expire ten years after the date of
grant. In addition, on the Effective Date, each of the three eligible
directors (other than the Chairman) were granted stock options to purchase
100,000 shares of Common Stock at an exercise price equal to the fair
market value on the day of grant.
Activity under the Stock Option Plans during the years ended December 31,
1996 and 1995 is as follows:
<TABLE>
<CAPTION>
1996 1995
------------------------ --------------------------
Weighted- Weighted-
Average Average
Exercise Exercise
Fixed Options Shares Price Shares Price
- ------------- ------ --------- ---------- -----------
<S> <C> <C> <C> <C>
Outstanding at beginning of
year........................ 1,281,866 $2.65 -- --
Granted....................... 500,000 4.77 1,281,866 $2.65
Exercised..................... -- -- -- --
Cancelled..................... -- -- -- --
---------- -------- ---------- ---------
Outstanding at end of year.... 1,781,866 $3.25 1,281,866 $2.65
---------- -------- ---------- ---------
---------- -------- ---------- ---------
Options exercisable at
year-end.................... 1,781,866 217,012
---------- ----------
---------- ----------
Option price range
at end of year................ $2.25 to $5.10 $2.25 to $4.74
-------------- --------------
-------------- --------------
Weighted average fair value
of options granted during
year........................ $3.94 $3.73
---------- ----------
---------- ----------
</TABLE>
The following table summarizes information about fixed options
outstanding at December 31, 1996.
<TABLE>
<CAPTION>
Options Outstanding Options Exercisable
---------------------------------------- -------------------------
Weighted-
Average Weighted- Weighted
Number Remaining Average Number Average
Range of Outstanding Contractual Exercise Exercisable Exercise
Exercise Prices at 12/31/96 Life Price at 12/31/96 Price
- ---------------- ----------- ----------- --------- ------------ ---------
<S> <C> <C> <C>
$2.25.................. 1,041,666 8.5 $2.25 1,041,666 $2.25
$4.31 to $4.74......... 240,200 9.0 4.40 240,200 4.40
$4.28 to $5.10......... 500,000 9.5 4.77 500,000 4.77
---------- ----- ------- ---------- -------
1,781,866 8.8 $3.25 1,781,866 $3.25
---------- ----- ------- ---------- -------
---------- ----- ------- ---------- -------
</TABLE>
The Company applies APB Opinion 25 and the related interpretations in
accounting for its plans. Accordingly, no compensation cost has been
recognized for these fixed option plans. Had compensation cost for the
Company's two option plans been determined consistent with FASB Statement
123, the Company's net income and earnings per share would have been reduced
to the pro forma amounts indicated below, based upon the following
assumptions:
The fair value of each option grant is estimated on the date of grant
using the Black-Scholes option-pricing model with the following
weighted-average assumption used in grants for 1995 and 1996, respectively:
dividend yield of 0% for both years; expected volatility of 54.2% for both
years, risk-free interest rates of 5.57% and 5.92% for the SOP, 6.42% and
6.46% for the SOPNED and 6.69% for the President's Options; and the expected
lives of 5 and 10 years for the SOP and 10 years for the SOPNED and the
President's Options.
<TABLE>
<CAPTION>
YEAR 1996 1995
------------- ----------
<S> <C> <C>
Net income (loss):
As reported....................................................... $1,405,462 $ 891,703
Pro forma......................................................... $ 106,199 $(2,269,103)
Primary earnings (loss) per share:
As reported....................................................... $0.09 $ 0.08
Pro forma......................................................... $0.01 $(0.20)
Fully diluted earnings (loss) per share:
As reported....................................................... $0.09 $0.08
Proforma.......................................................... $0.01 $(0.20)
</TABLE>
10. INCOME TAXES:
A reconciliation of the enacted tax rate to the effective rate reflected
in the financial statements is as follows for the years ended December 31,
1996 and 1995:
F-13
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
10. INCOME TAXES, continued:
<TABLE>
<CAPTION>
1996 1995
--------- ---------
<S> <C> <C>
Statutory rate................................... 34.0% 34.0%
Tax-free interest income......................... (3.4%) (4.3%)
Effective state rate (net of Federal benefit).... 1.5% 1.7%
Other, net....................................... 0.7% 3.3%
--------- ---------
Effective rate in financial statements........... 32.8% 34.7%
--------- ---------
--------- ---------
</TABLE>
There are no material differences between financial and income tax reporting
which would give rise to deferred income taxes at December 31, 1996 and 1995.
11. PREFERRED STOCK:
The Company has authorized the issuance of 1,000,000 shares of preferred
stock with the rights, preferences, limitations and redemption of the
preferred stock determined upon any issuances.
12. CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS:
The Company derives a majority of its revenue from companies owned,
controlled by, or affiliated with the Chairman and principal stockholder of
the Company which subjects accounts receivable and revenue to concentrations
of credit risk. At times, cash balances may exceed FDIC limits. Also, the
Company invests in cash equivalents that are collateralized by letters of
credit issued by PNC Bank, N.A. At December 31, 1996 and 1995, cash
equivalents of $895,000 and $6,065,000 were collateralized by such letters.
13. PUBLIC OFFERING:
On August 3, 1995, the Company's registration statement on Form SB-2 was
declared effective by the Securities and Exchange Commission. The Company
issued 4,000,000 shares of common stock to the) public at $2.00 per share. The
Company realized approximately $6,500,000 in net proceeds from the offering.
On August 21, 1995, the Underwriters exercised their option to purchase
600,000 additional shares of common stock for the purpose of covering
over-allotments. The Company realized approximately $1,050,000
in net proceeds from the sale of these additional shares.
14. RELATED PARTY TRANSACTIONS:
The Company was a party to a contract to receive management and
consulting services with Medical Business Systems, Inc. ("MBS"). MBS was owned
by the President, CEO and Director of the Company. The contract provided for
a fixed fee of $12,500 per month. The Company incurred $62,500 in charges for
the year ended December 31, 1995 with MBS. Effective June 1, 1995, the
President, CEO and Director of the Company became employed by the Company
pursuant to an employment agreement.
Effective October 1, 1994, the Company executed contracts to provide
billing, accounts receivable and collection services with numerous entities
that are owned, controlled by, or affiliated with the Chairman and principal
stockholder of the Company. The Company receives a percentage
F-14
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
14. RELATED PARTY TRANSACTIONS, continued:
of patient net revenues of the clients as compensation for its services. To
date the majority of the Company's revenues are from related parties. The
contracts are scheduled to expire as of September 30, 1997. Management of the
Company is presently negotiating their renewal. At this time it is
management's expectation to have them renewed, but no assurances can be made
at this time.
The contracts entered into by the Company as of October 1, 1994 with
certain entities were amended as of January 1, 1995 to provide for a reduced
percentage of revenue to be earned by the Company. Other contracts were
amended to include an expanded level of services at the current fee structure
agreed upon at their inception. At December 31, 1996 and 1995 $362,200 and
$1,836,854, respectively, in accounts receivable-billed are from entities
owned, controlled by, or affiliated with the Chairman and principal
stockholder of the Company.
During 1995, the Company was reimbursed $55,000 for services rendered by
the Chief Financial Officer to companies owned, controlled by, or affiliated
with the Chairman and principal stockholder of the Company. No such monies
were received in 1996.
15. BUSINESS ACQUISITION:
In June 1995, the Company acquired the cash, accounts receivable and
client contracts of a billing and collection company that provides services
to medical service providers. The total consideration paid for the
aforementioned assets was $1,050,000 in cash plus 500,000 shares of the
Company's common stock based on a value of $2.00 per share. An additional
5,000 shares in lieu of interest were issued on October 1, 1995 in connection
with this transaction.
The terms of the transaction allow for an adjustment in the purchase
price based upon the monthly average of the actual client fees collected
during specified periods. The transaction was accounted for by the purchase
method of accounting.
Subsequent to the asset acquisition by the Company, the Chairman and
principal stockholder of the Company acquired the stock of the billing and
collection company for $1.00. The fair market value of the billing and
collection company was negligible at that time.
The pro forma unaudited results of operations for the twelve months ended
December 31, 1995, assuming the consummation of the purchase described above,
as of January 1, 1995, are as follows:
<TABLE>
<CAPTION>
1995
------------
<S> <C>
Revenues....................................... $6,703,973
Net income..................................... 1,008,438
Net income per share........................... $0.09
</TABLE>
16. CONTRACT ACQUISITIONS:
On August 1, 1996, the Company acquired seven contracts from Rapier
Investments Ltd. ("Rapier") to provide billing, collection and accounts
receivable management services to medical service providers in Massachusetts
and New Hampshire. The total consideration paid was $945,000, consisting of
$750,000 in cash and 42,740 shares of common stock based on a value of
$4.56 per share. In accordance with the purchase agreement, the Company
placed these
F-15
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
16. CONTRACT ACQUISITIONS, continued:
share into escrow. Fewer shares will ultimately be released if certain
revenue levels are not maintained.
On April 1, 1996, the Company acquired the accounts receivable and client
contracts from National Medical Services, Inc. The client contracts related
to this acquisition provide billing and collection services to approximately
19 medical service providers in the Las Vegas, Nevada area. The total
consideration paid for this acquisition was $550,000, consisting of $250,000
in cash and 60,000 shares of common stock valued at $5.00 per share. In
accordance with the purchase agreement, the Company placed these shares into
escrow. Fewer shares will ultimately be released if certain revenue levels
are not maintained.
On February 13, 1996, the Company acquired the accounts receivable and
client contracts from Doctors Medical Billing Services, A limited Liability
Corporation. The client contracts related to this acquisition provide billing
and collection services to approximately 25 medical service providers in Las
Vegas, Nevada area. The total consideration paid was $1,800,000, consisting
of $150,000 in cash and 388,236 shares of common stock based on a value of
$4.25 per share. In accordance to the purchase agreement, the Company placed
these shares into escrow. Fewer shares will ultimately be released from
escrow if certain revenue levels are not maintained.
On December 1, 1995, the Company acquired a billing contract between
Rapier and University Emergency Medical Foundation, Inc. The total
consideration paid was $750,000, consisting of $650,000 in cash and 27,118
shares of common stock, based on a value of $3.69 per share. In accordance
with the purchase agreement, the Company placed these shares into escrow.
Fewer shares will ultimately be released from escrow if certain revenue
levels are not maintained. As the contract acquired was part of a larger
group of contracts and was not accounted for separately, information
regarding the pro forma results of operations for the twelve months ended
December 31, 1995, assuming consummation of the purchase as of January 1,
1995 is not available.
17. LEGAL MATTERS:
The Company is not presently involved in any material pending litigation or
proceeding.
18. PENDING CONTRACT ACQUISITIONS:
The Company is negotiating to purchase billing contracts of Medical
Service Providers in the Phoenix, Arizona area. As of December 31, 1996, the
Company made a $150,000 working capital loan to the acquisition candidate. In
addition, the Company has paid $490,00 in finders fees to First United. It is
managements' belief that the acquisition will be consummated and the costs
will be capitalized as acquisition costs during 1997. If the contracts are
not acquired, the costs will be expensed in the appropriate period during 1997.
19. SUBSEQUENT EVENTS:
On February 4, 1997, the Board of Directors of the Company authorized a
two for one stock split and a corresponding increase in the number of
authorized shares of the Company to 40,000,000 shares pursuant to Section
78.207 of the Nevada General Corporation Law (the "Stock Split"). The
stockholders of record as of February 17, 1997 (the "Record Date") will
receive one additional share of the Company's common stock for each share of
common stock held of record as of the Record Date. The Stock Split was
distributed on February 24, 1997 and all stock related data in the financial
statements reflect the Stock Split for all periods presented.
Effective February 1, 1997, the President, Chief Executive Officer and
Director of the Company resigned from his offices and employment by mutual
consent with the Company. The Employment Contract with the Company was
terminated. The options granted to the former President and Chief Executive
Officer under the Stock Option Plan on December 20, 1995 will remain
exercisable until their respective expiration dates. The Company has retained
MBS as a marketing and acquisition consultant for the time period from
February 1, 1997 until May 31,
F-16
<PAGE>
NOTES TO THE FINANCIAL STATEMENTS, Continued
19. SUBSEQUENT EVENTS, continued:
1998. The agreement provides for a $14,227 monthly payment. The former
President and Chief Executive Officer of the Company is an officer of MBS. In
addition, the Company is in the process of assigning its non-cancelable
operating leases for the Massachusetts office to Rapier. Rapier owns and
controls MBS, which the former President and Chief Executive Officer of the
Company is an officer.
On March 1, 1997, the Company acquired a contract to provide billing and
collection services to an emergency medical group in Rhode Island. The total
consideration paid was $164,998, consisting of $100,000 in cash and 14,444
shares of common stock, based on a value of $4.50 per share. In accordance
with the purchase agreement, the Company placed these shares into escrow.
Fewer shares will ultimately be released from escrow if certain revenue
levels are not maintained. The Company has contracted with Rapier to provide
billing, accounts receivable and collection services for this contract with
of the Company. The contract provides for the Company to pay Rapier 70% of
all revenues collected by the Company for the performance of such services.
Rapier owns and controls MBS, which the former President and Chief Executive
Officer of the Company is an officer.
On March 1, 1997, the Company acquired a contract to provide billing and
collection services to an emergency medical group in the Cleveland, Ohio
area. The total consideration paid was $499,998, consisting of $300,000 in
cash and 44,444 shares of common stock, based on a value of $4.50 per
share. In accordance with the purchase agreement, the Company placed these
shares into escrow. Fewer shares will ultimately be released from escrow if
certain revenue levels are not maintained. The Company has contracted with
MBS to provide billing, accounts receivable and collection services for this
contract with of the Company. The contract provides for the Company to pay
MBS 70% of all revenues collected by the Company for the performance of such
services. The former President and Chief Executive Officer of the Company is
an officer of MBS.
Effective March 14, 1997, the Board of Directors appointed the Chairman
and principal stockholder of the Company to serve as the President and Chief
Executive Office of the Company, as well as the previous positions he
currently maintains in the Company.
F-17
<PAGE>
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of
1934, the Registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
NATIONAL MEDICAL FINANCIAL SERVICES
CORPORATION
By: /s/ Douglas R. Colkitt, M.D.
------------------------------------
Douglas R. Colkitt, M.D., Chairman,
President and Chief Executive Officer
SIGNATURES
In accordance with the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the Registrant and
in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signatures Title Date
- ---------- ----- ----
<S> <C> <C>
/s/ Douglas R. Colkitt, M.D. Chairman, President and April 15, 1997
- ---------------------------- Chief Executive Officer
Douglas R. Colkitt, M.D. (Principal Executive Officer)
/s/ Robert W. Horner, Jr. Vice President, Chief Financial Officer, April 15, 1997
- ---------------------------- Treasurer and Secretary (Principal
Robert W. Horner, Jr. Financial and Accounting Officer)
/s/ Jude J. Spak Director April 15, 1997
- ----------------------------
Jude J. Spak
/s/ Richard L. Flickinger Director April 15, 1997
- ----------------------------
Richard L. Flickinger
/s/ Robert M. Colkitt Director April 15, 1997
- ----------------------------
Robert M. Colkitt
</TABLE>
